Pharmaceutical companies are developing upgraded versions of existing hair-loss treatments and introducing novel therapies, marking a significant shift in the dermatology sector. These advancements include enhanced formulations of traditional drugs and innovative approaches like 'Botox on steroids,' which could expand the billion global hair-care market. Investors are watching closely as improved efficacy and reduced side effects may drive adoption, benefiting biotech firms and pharmaceutical giants. The trend reflects growing demand for aesthetic medicine and could influence healthcare investment strategies.
مباشر